Literature DB >> 16467680

Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid.

Xiaoguang Dong1, Nan Chen, Lixin Xie, Shenguo Wang.   

Abstract

PURPOSE: To evaluate the antiproliferative effect of an all-trans retinoic acid (at-RA) drug delivery system (DDS) on experimental proliferative vitreoretinopathy (PVR).
METHODS: PVR was induced in rabbits with core vitrectomy and fibroblast injection. The DDS containing 420 microg, 650 microg, and 1,070 microg of at-RA was implanted into the vitreous of treated groups B, C, and D, respectively. Group A with no DDS and group E with nonmedicated DDS served as controls. The intravitreal at-RA concentration was measured with high-pressure liquid chromatography. The drug toxicity was evaluated histologically.
RESULTS: The severity of PVR was significantly reduced in groups C and D but not in groups A, B, and E. The drug release peaked at 6 weeks to 7 weeks. No signs of retinal toxicity were found in the DDS groups.
CONCLUSION: Intravitreal implantation of at-RA DDS appears effective in inhibiting the development of PVR and is well tolerated in rabbit eyes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467680     DOI: 10.1097/00006982-200602000-00015

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  2 in total

1.  Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.

Authors:  Shuhei Kawahara; Yasuaki Hata; Takeshi Kita; Ryoichi Arita; Muneki Miura; Shintaro Nakao; Yasutaka Mochizuki; Hiroshi Enaida; Tadahisa Kagimoto; Yoshinobu Goto; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Diabetes       Date:  2008-07-03       Impact factor: 9.461

2.  Modulated release from implantable ocular silicone oil tamponade drug reservoirs.

Authors:  Helen Cauldbeck; Maude Le Hellaye; Tom O McDonald; Mark Long; Rachel L Williams; Steve P Rannard; Victoria R Kearns
Journal:  J Polym Sci A Polym Chem       Date:  2018-02-09       Impact factor: 2.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.